{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:04:01Z","timestamp":1764687841212,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GSK"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boehringer Ingelheim"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boehringer Ingelheim"},{"DOI":"10.13039\/100007560","name":"Chiesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GSK"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GSK"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boehringer Ingelheim"},{"name":"MSD"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.rmcr.2019.100967","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T12:01:45Z","timestamp":1574164905000},"page":"100967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Long-term responsiveness to mepolizumab after failure of omalizumab and bronchial thermoplasty: Two triple-switch case reports"],"prefix":"10.1016","volume":"29","author":[{"given":"Carlo","family":"Lombardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Menzella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Passalacqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmcr.2019.100967_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000338998","article-title":"The cost of persistent asthma in Europe: an international population-based study in adults","volume":"160","author":"Accordini","year":"2013","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.rmcr.2019.100967_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2500\/aap.2016.37.3941","article-title":"A perspective on systemic corticosteroid therapy in severe bronchial asthma in adults","volume":"37","author":"Klaustermeyer","year":"2016","journal-title":"Allergy Asthma Proc."},{"issue":"1","key":"10.1016\/j.rmcr.2019.100967_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40413-016-0130-3","article-title":"Therapeutic interventions in severe asthma","volume":"9","author":"Canonica","year":"2016","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.rmcr.2019.100967_bib4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2147\/TCRM.S86299","article-title":"Clinical usefulness of mepolizumab in severe eosinophilic asthma","volume":"12","author":"Menzella","year":"2016","journal-title":"Ther. Clin. Risk Manag."},{"issue":"3","key":"10.1016\/j.rmcr.2019.100967_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1398-9995.2004.00772.x","article-title":"Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE","volume":"60","author":"Humbert","year":"2005","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.rmcr.2019.100967_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4168\/aair.2017.9.1.3","article-title":"Development of new therapies for severe asthma","volume":"9","author":"Fajt","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.rmcr.2019.100967_bib8","first-page":"CD003559","article-title":"Omalizumab for asthma in adults and children","volume":"1","author":"Normansell","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.rmcr.2019.100967_bib9","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.rmed.2007.01.011","article-title":"Predicting and evaluating response to omalizumab in patients with severe allergic asthma","volume":"101","author":"Bousquet","year":"2007","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmcr.2019.100967_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/resp.13424","article-title":"Predicting response to bronchial thermoplasty in patients with severe uncontrolled asthma: an elusive goal","volume":"24","author":"Hall","year":"2019","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.rmcr.2019.100967_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pupt.2012.08.005","article-title":"Phenotype modulation of airway smooth muscle in asthma","volume":"26","author":"Wright","year":"2013","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.rmcr.2019.100967_bib13","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/all.12914","article-title":"Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment","volume":"71","author":"Magnan","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.rmcr.2019.100967_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/all.13850","article-title":"The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma","author":"Chapman","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.rmcr.2019.100967_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/all.13937","article-title":"Efficacy of mepolizumab in patients with previous omalizumab treatment failure: real-life observation","author":"Bagnasco","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.rmcr.2019.100967_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/JAA.S176026","article-title":"Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study","volume":"11","author":"Price","year":"2018","journal-title":"J. Asthma Allergy"},{"issue":"1","key":"10.1016\/j.rmcr.2019.100967_bib17","doi-asserted-by":"crossref","first-page":"100007","DOI":"10.1016\/j.waojou.2018.12.001","article-title":"Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry","volume":"12","author":"Canonica","year":"2019","journal-title":"World Allergy Organization J"}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007119302771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007119302771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:03:06Z","timestamp":1761958986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007119302771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":15,"alternative-id":["S2213007119302771"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2019.100967","relation":{},"ISSN":["2213-0071"],"issn-type":[{"type":"print","value":"2213-0071"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term responsiveness to mepolizumab after failure of omalizumab and bronchial thermoplasty: Two triple-switch case reports","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2019.100967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100967"}}